Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Times Interest Earned (2022 - 2025)

Tarsus Pharmaceuticals has reported Times Interest Earned over the past 4 years, most recently at -$3.6 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$3.6 for Q4 2025, up 65.89% from a year ago — trailing twelve months through Dec 2025 was -$7.94 (up 48.29% YoY), and the annual figure for FY2025 was -$7.94, up 48.29%.
  • Times Interest Earned for Q4 2025 was -$3.6 at Tarsus Pharmaceuticals, up from -$6.41 in the prior quarter.
  • Over the last five years, Times Interest Earned for TARS hit a ceiling of -$3.6 in Q4 2025 and a floor of -$61.78 in Q1 2022.
  • Median Times Interest Earned over the past 4 years was -$18.78 (2024), compared with a mean of -$25.34.
  • Biggest five-year swings in Times Interest Earned: crashed 319.36% in 2023 and later soared 78.43% in 2024.
  • Tarsus Pharmaceuticals' Times Interest Earned stood at -$21.76 in 2022, then tumbled by 106.5% to -$44.94 in 2023, then skyrocketed by 76.5% to -$10.56 in 2024, then surged by 65.89% to -$3.6 in 2025.
  • The last three reported values for Times Interest Earned were -$3.6 (Q4 2025), -$6.41 (Q3 2025), and -$9.9 (Q2 2025) per Business Quant data.